Target intelligence / Profile preview

Paracrine-mediated tissue targets

Molecular classification
Other
01

Overview

Paracrine-mediated tissue targets refer to the specific cells and molecular receptors within a tissue that respond to local chemical signals released by neighboring cells (Source: Wikipedia). This form of communication, known as paracrine signaling, involves the secretion of factors such as growth factors, cytokines, and morphogens that diffuse over short distances to elicit specific biological responses in nearby target cells (Source: Danaher). These targets are essential for coordinating localized physiological processes, including embryonic development, tissue regeneration, and the regulation of immune responses (Source: NIH). In therapeutic contexts, this concept is central to both oncology—where drugs like bevacizumab block pathological paracrine signals (e.g., VEGF)—and regenerative medicine, where stem cell-derived factors and exosomes are used to deliver therapeutic cargo to injured tissue targets to promote repair (Source: Nature, Paracrine Therapeutics). While the term does not refer to a single molecule, it encompasses a broad range of specific receptors and signaling pathways that are critical for local tissue homeostasis and disease progression.

Other names
Paracrine signaling targetsLocal tissue targetsParacrine-responsive cellsParacrine-mediated pathways
02

Mechanism of action

Modulation of local intercellular communication by targeting secreted ligands or their cognate receptors on nearby cells.

03

Biological functions

Signal transductionCell-cell communicationTissue repairImmune responseCell proliferationCell differentiation
04

Disease associations

CancerInflammationCardiovascular diseaseNeurodegenerative diseaseDiabetes (e.g., diabetic foot ulcers)
05

Safety considerations

Off-target effects in healthy tissuesImpaired wound healingSystemic toxicity from modulating local pathwaysInconsistent therapeutic cargo in cell-based products
06

Interacting drugs

Bevacizumab

4 more in the full profile.

07

Biomarkers

VEGF expressionIL-6 levelsExosomal miRNA profilesTissue-specific receptor expression (e.g., HER2, FGFR)

Beyond the preview

Go deeper on Paracrine-mediated tissue targets.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Paracrine-mediated tissue targets.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call